You need to register separately on the Chart Forum
- see Chart Forum Help
Edit Profile Profile Help Help
Forum Rules Forum Rules Advanced Help/Instructions Advanced Help
Search Last 1|3|7 Days Latest Posts Latest Posts
Search Search Forum Tree View Tree View
   
Trade Trends with Bollonger Bands and Twiggs Money Flow

Gene Therapy Companies...

Chart Forum » Stocks - ASX: long term & fundamental » Gene Therapy Companies...

««  Previous  Next  »»


 
Thread Start New Thread 
Last Poster Posts Pages Last Post
         

Author Message

Top of pagePrevious messageNext messageBottom of page Link to this message
spdfgh
Member
Username: spdfgh

Post Number: 463
Registered: 06-2004

Rating: N/A
Votes: 0


Monday, December 31, 2018 - 08:51 pm:Copy highlighted text to 'New Message' boxEdit Post Delete Post Print Post    View Post/Check IP (Moderator/Admin only) Ban Poster IP (Moderator/Admin only) Move Post (Moderator/Admin Only)



2019 could very well be the year for gene therapy companies.
Two that come to mind are CYP and IMU. Both appear to be in stage II trials.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cynata Therapeutics (CYP)
Company Overview
Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform.

Former Names
Senevens International Limited (SVN), 5/12/2008; Eco Quest Limited (ECQ), 15/11/2013.



Recent Announcements:
20/12/2018 End of Year Newsletter
18/12/2018 Cynata Completes Clinical Study Report in GvHD
13/12/2018 NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs
19/11/2018 Cynata Receives $1.3m R&D Tax Incentive Refund


https://www.marketindex.com.au/asx/cyp



- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Imugene Limited (IMU)

Company Overview
Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical Company developing HER2 + ve gastric and breast cancer vaccines. The Group's lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu.

Former Names
Vostech Limited (VOS), 26/08/2002; Vos Industries Limited (VOS), 28/12/2000; Vosfry Systems Australia Pty Ltd (VOS), 19/01/1990.

17/12/2018 IMU Meets Endpoints in Phase 1b Gastric Cancer Trial
13/11/2018 Imugene Advances to Phase 2 in Gastric Cancer Trial 4 375k 9:21am
09/11/2018 Imugene Receives $1.85 million R&D Tax Incentive 2 104k 9:11am




Just another potato.

Add Your Message Here
Post:
Bold text Italics Underline Create a hyperlink Insert a clipart image

Username: Posting Information:
This is a private posting area. Only registered users and moderators may post messages here.
Password:
Options: Enable HTML code in message
Automatically activate URLs in message
Action:

 
Other Threads  
Last PosterPostsPagesLast Post
Charter Hall Group CHCscarlettsmith69405-Sep-19  09:27 pm
BVS - Bravura Solutionsscarlettsmith69414 17-Jun-19  03:09 pm
CXO - Is on the Lithium trial in NTscarlettsmith69427-May-19  08:18 pm
BGS - The untold storypeterloh11-Mar-19  09:24 pm
4DS Memory Limited (4DS)spdfgh02-Feb-19  07:07 pm
BWP Trust Ordinary Units FP (BWP)spdfgh08-Dec-18  09:28 am
CWY spdfgh08-Dec-18  08:58 am
WOW Woolworths Group LTDspdfgh20-Nov-18  09:10 pm
AMP LTDshadetreetrader27-Oct-18  06:20 am
Trading Diary - Never waste a good crisis...spdfgh24-Oct-18  07:11 pm
Northern Star Resources NSTdydavo19-Oct-18  10:29 am
A2M - A2 Milk Coshadetreetrader13 13-Oct-18  09:00 am
BHPspdfgh68 11-Oct-18  08:45 pm
Long term breakout loomingspdfgh11-Oct-18  08:37 pm

Threads by Last Post Time:

First Previous 0 1 2 3 4 Next Last

Administration Administration   Log Out Log Out    

««  Previous  Next  »»